103 related articles for article (PubMed ID: 9093386)
1. Micronucleated cells during the growth of the Ehrlich ascites tumour on spontaneous and by titanocenedichloride-induced conditions.
Tarillion P; Taubert G; Nenning H
Mutat Res; 1997 Mar; 389(2-3):213-8. PubMed ID: 9093386
[TBL] [Abstract][Full Text] [Related]
2. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
3. Induction of cell arrest at G1/S and in G2 after treatment of Ehrlich ascites tumor cells with metallocene dichlorides and cis-platinum in vitro.
Köpf-Maier P; Wagner W; Liss E
J Cancer Res Clin Oncol; 1983; 106(1):44-52. PubMed ID: 6684118
[TBL] [Abstract][Full Text] [Related]
4. Immunologic response to the treatment of Ehrlich ascites tumor with titanocene dichloride.
Köpf-Maier P; Hesse A
J Cancer Res Clin Oncol; 1984; 108(2):254-5. PubMed ID: 6540782
[TBL] [Abstract][Full Text] [Related]
5. Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum(II) and metallocene dichlorides.
Köpf-Maier P; Wagner W; Liss E
J Cancer Res Clin Oncol; 1981; 102(1):21-30. PubMed ID: 7199526
[TBL] [Abstract][Full Text] [Related]
6. Titanocene dichloride--the first metallocene with cancerostatic activity.
Köpf H; Köpf-Maier P
Angew Chem Int Ed Engl; 1979 Jun; 18(6):477-8. PubMed ID: 111586
[No Abstract] [Full Text] [Related]
7. The effect of a Titanocene Dichloride derivative, Ti IV (C5H5)(2) NCS(2), on the haematopoietic response of Ehrlich tumour-bearing mice.
Valadares MC; Queiroz ML
Eur J Pharmacol; 2002 Mar; 439(1-3):35-42. PubMed ID: 11937090
[TBL] [Abstract][Full Text] [Related]
8. In vitro cell growth inhibition by metallocene dichlorides.
Köpf-Maier P; Wagner W; Köpf H
Cancer Chemother Pharmacol; 1981; 5(4):237-41. PubMed ID: 7261252
[TBL] [Abstract][Full Text] [Related]
9. Early effects of cis-dichlorodiammine platinum (II) on tumor progression and programmed death of Ehrlich ascites carcinoma cells.
Razin BV; Inzhevatkin EV; Nefedova VV; Egorova AB; Kazbanov VI; Nefedov VP
Bull Exp Biol Med; 2001 Jun; 131(6):568-9. PubMed ID: 11586409
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin treatment induces dose-dependent increases in the frequency of micronuclei in Ehrlich ascites tumor cells.
Quintana E; Pertusa J; González R; Renau-Piqueras J
Mutat Res; 1994 Jul; 322(1):55-60. PubMed ID: 7517504
[TBL] [Abstract][Full Text] [Related]
11. Pattern of toxicity by titanocene dichloride in mice: hematologic parameters.
Köpf-Maier P; Gerlach S
Anticancer Res; 1986; 6(2):235-40. PubMed ID: 3707061
[TBL] [Abstract][Full Text] [Related]
12. [Tumor inhibition by metallocenes: effect of titanocene, zirconocene, and hafnocene dichlorides on Ehrlich ascites tumor in mice (author's transl)].
Köpf-Maier P; Hesse B; Köpf H
J Cancer Res Clin Oncol; 1980 Jan; 96(1):43-51. PubMed ID: 7188941
[TBL] [Abstract][Full Text] [Related]
13. Titanocene modulation of cytokine imbalance induced by Ehrlich ascites tumour progression.
Valadares MC; Klein SI; Queiroz ML
Eur J Pharmacol; 2004 Oct; 503(1-3):203-8. PubMed ID: 15496315
[TBL] [Abstract][Full Text] [Related]
14. Teratogenicity and embryotoxicity of titanocene dichloride in mice.
Köpf-Maier P; Erkenswick P
Toxicology; 1984 Nov; 33(2):171-81. PubMed ID: 6506085
[TBL] [Abstract][Full Text] [Related]
15. Antitumor metallocenes: new developments and toxicologic features.
Köpf-Maier P; Köpf H
Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060
[TBL] [Abstract][Full Text] [Related]
16. Ionic titanocene complexes: a new type of antitumor agent.
Köpf-Maier P; Neuse E; Klapötke T; Köpf H
Cancer Chemother Pharmacol; 1989; 24(1):23-7. PubMed ID: 2720888
[TBL] [Abstract][Full Text] [Related]
17. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
Nersesyan A; Muradyan R; Arsenyan F
J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of titanocenedichloride in human renal cell carcinoma compared to conventional antineoplastic agents.
Kurbacher CM; Nagel W; Mallmann P; Kurbacher JA; Sass G; Hübner H; Andreotti PE; Krebs D
Anticancer Res; 1994; 14(4A):1529-33. PubMed ID: 7979181
[TBL] [Abstract][Full Text] [Related]
19. Pattern of toxicity by titanocene dichloride in mice. Blood and urine chemical parameters.
Köpf-Maier P; Gerlach S
J Cancer Res Clin Oncol; 1986; 111(3):243-7. PubMed ID: 3733855
[TBL] [Abstract][Full Text] [Related]
20. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
Socaciu C; Bara A; Silvestru C; Haiduc I
In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
